The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a 5-year, $42,680,510 Cooperative Agreement under the Global AIDS (CFDA 93.067) program to the Shwari Health Association in Yaoundé, Cameroon. The funding will support the "SUSTAIN ADVANCED FACILITY AND COMMUNITY-BASED HIV CASCADE ACTIVITIES IN CAMEROON (SAFECARE-CAMEROON)" project, which aims to strengthen HIV prevention, testing, treatment, and care services in Cameroon. Key...
This federal Cooperative Agreement award, with a total funding of $15,221,142, was granted by the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067). The award aims to develop, implement, and sustain high-quality comprehensive facility and community-based HIV 95-95-95 cascade activities for children, adolescents, and adults in Cameroon, under the President's Emergency Plan for AIDS Relief (PEPFAR). Key objectives include increasing enrollment in...
This Cooperative Agreement award from the Department of Defense (DoD) HIV/AIDS Prevention Program (DHAPP) provides $200,000 in funding to the Network for Religious Leaders Living With or Affected By HIV/AIDS LIMITED in Malawi. The project, titled "DHAPP-MDF Partnership for Sustainable HIV Epidemic Control Through Improved Linkage to HIV Services by Faith Community Leaders (PASHEC)," aims to train and assist the Malawi Defense Force (MDF) in establishing and implementing HIV/AIDS...
The U.S. Department of Defense HIV/AIDS Prevention Program (DHAPP), CFDA 12.350, has awarded a $385,000 Cooperative Agreement to Hands On Care, a non-profit organization in The Gambia. The purpose of this 1-year award, effective September 30, 2024, is to provide technical assistance, prevention, care, and treatment services to address HIV/AIDS within the Gambian military population and their dependents. The project aims to reduce HIV transmission, implement prevention strategies, expand...
This $5,023,124 Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) under the Global AIDS Federal Grant Program (CFDA 93.067), supports the National Tuberculosis Control Program in Cameroon to combat HIV/AIDS. The 5-year award, from September 2024 to September 2029, will strengthen national health systems, expand access to antiretroviral therapy, improve laboratory capabilities, enhance data management systems, and support community-based interventions...
This Cooperative Agreement award of $100,000 from the Department of State Bureau of African Affairs will support Health Development Consultancy Services (Hedecs) to improve HIV service delivery and outcomes for key populations in eight regions of Cameroon through September 2023. Funded through the U.S. President's Emergency Plan for AIDS Relief Programs (PEPFAR; CFDA #19.029), Hedecs will identify and understand data-driven solutions to overcome barriers and ensure key populations receive...
The Defense Health Agency awarded Jhpiego Corporation $933,052 under a Cooperative Agreement from October 1, 2021 to September 30, 2023 to support the Department of Defense HIV/AIDS Prevention Program. As part of this award, Jhpiego will provide reproductive, maternal, newborn, child, and adolescent health services, family health and nutrition activities, voluntary medical male circumcision and pre-exposure prophylaxis services, and health system performance improvement efforts to the Botswana...
Metabiota, Inc. was awarded a $3.5 million cooperative agreement from the Defense Health Agency under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350) for the period of October 1, 2021 through September 30, 2023. The award will support Metabiota's efforts to build HIV epidemic control in Cameroon through strengthening HIV prevention, testing, linkage to care and treatment, and viral suppression programs within the Cameroon Defense Force. As part of this cooperative...
The federal Cooperative Agreement award, with identification number HT94252420017, was provided by the Defense Health Agency under the Department of Defense HIV/AIDS Prevention Program (CFDA 12.350). The $184,767.82 award, with a period of performance from September 30, 2024 to September 29, 2025, supports the Alliance Nationale Contre LE Sida, a non-profit organization based in Dakar, Senegal. The funding is intended to provide technical assistance, prevention, care, and treatment services to...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $21,735,374 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) to develop, implement, and sustain high-quality comprehensive facility and community-based HIV activities in Cameroon. The 5-year award, spanning from Sep 30, 2024 to Sep 29, 2029, will support EGPAF's efforts to strengthen local health systems, support government health institutions, and...